Product Name: Trelagliptin Succinate
CAS No.: 1029877-94-8
Molecular Formula: C22H26FN5O6
Molecular Weight: 475.48 g/mol

Product Description:
Trelagliptin succinate is a long-acting, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor used as an antidiabetic agent for type 2 diabetes.

Mechanism of Action:
- Inhibits DPP-4 with an IC50 of 4 nM
- Reduces degradation of GLP-1 and GIP
- Enhances insulin secretion

Therapeutic Features:
- Designed for once-weekly dosing regimens
- Improves glycemic control
- Enhances patient compliance

Product Category: Active Pharmaceutical Ingredients (APIs) / Pharmaceutical Intermediates / Antidiabetic Agents

Applications:
- Type 2 diabetes treatment
- Pharmaceutical manufacturing
- Research and development

Advantages:
- Long-acting formulation
- Once-weekly dosing
- High potency (IC50 = 4 nM)
- Effective glycemic control

Quality: High-purity API grade

Note: For pharmaceutical manufacturing and research purposes only.

Analytical Reference Standards: Available via LGC Standards for quality control and testing.